MTFB Motif Bio Plc

TIDMMTFB

RNS Number : 5169S

Motif Bio PLC

21 December 2016

Motif Bio plc

("Motif Bio" or the "Company")

Result of GM

Motif Bio plc (AIM: MTFB) the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that all resolutions put to shareholders at the Company's General Meeting held earlier today were duly passed.

For further information please contact:

 
 Motif Bio plc                          info@motifbio.com 
 Graham Lumsden (Chief 
  Executive Officer) 
 
 Zeus Capital Limited 
  (NOMAD & BROKER)                    +44 (0)20 3829 5000 
 Phil Walker/Giles Balleny 
 Dominic Wilson 
 
 Northland Capital Partners 
  Limited (BROKER)                    +44 (0)203 861 6625 
 Patrick Claridge/ David 
  Hignell 
 John Howes/ Rob Rees 
  (Broking) 
 
 Walbrook PR Ltd. (FINANCIAL      +44 (0) 20 7933 8780 or 
  PR & IR)                        motifbio@walbrookpr.com 
 Paul McManus                        Mob: +44 (0)7980 541 
                                                      893 
 Mike Wort                           Mob: +44 (0)7900 608 
                                                      002 
 
 MC Services AG (EUROPEAN 
  IR)                                  +49 (0)89 210 2280 
 Raimund Gabriel 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ROMEFLFLQLFBFBX

(END) Dow Jones Newswires

December 21, 2016 10:05 ET (15:05 GMT)

Motif Bio (LSE:MTFB)
Historical Stock Chart
From Apr 2024 to May 2024

Motif Bio (LSE:MTFB)
Historical Stock Chart
From May 2023 to May 2024